<DOC>
	<DOCNO>NCT00435942</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy Relay thoracic stent-graft system treat thoracic aortic aneurysm . Efficacy evaluate device-related adverse event rate endovascular repair ( via Relay Thoracic Stent-Graft ) 1-year . Safety evaluate compare major adverse event 1-year subject treat Relay Thoracic Stent-Graft underwent surgical repair .</brief_summary>
	<brief_title>Phase II Study Safety Efficacy Relay Thoracic Stent-Graft</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Thoracic</mesh_term>
	<criteria>Subjects diagnose descend thoracic aortic aneurysm penetrate atherosclerotic ulcer Subjects least 18 year age Subjects whose anatomy accommodate Relay device Subjects consent participate Subjects agree comply followup schedule Subjects nonaneurysm lesion Subjects less 1 year life expectancy Subjects pregnant Subjects medical condition would complicate endovascular procedure confound result ( e.g. , Marfan 's Syndrome , prior repair thoracic aorta , severe coronary artery disease , morbid obesity , etc . ) Subjects participate another investigational study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>